Roche secures CE mark for its SmartGuide, enabling glucose monitoring technology
Roche, a leading healthcare company, has announced the expansion of its diabetes management solution with the availability of the Accu-Check SmartGuide in combination with the mySugr app. Currently available in 13 countries, the Accu-Check SmartGuide is planned to be offered in over 30 countries by the end of the year, reaching Europe, Latin America, and the Asia-Pacific region.
The combination of the Accu-Check SmartGuide and mySugr is designed to provide a more comprehensive solution for diabetes management, offering improved capabilities to an expanded global user base. This collaboration is expected to have a significant impact on diabetes management in various regions around the world.
The Accu-Check SmartGuide is a portable, AI-assisted monitoring device intended for use by people with diabetes for improved management of their condition. By combining it with the mySugr app, users can access a range of features aimed at simplifying diabetes management, including tracking blood glucose levels, logging meals, and receiving personalized insights and advice.
Roche's announcement marks a significant step forward in comprehensive care for people with diabetes. The availability of the Accu-Check SmartGuide with mySugr is being expanded to reach more people with diabetes worldwide. In addition to the initial 13 countries, the device is now available in an additional 17 countries, bringing the total to 20 countries.
The Accu-Check SmartGuide and mySugr are expected to be available in countries outside of the initial 13, including North America and Africa, in the coming months. This expansion is expected to contribute to better diabetes care in a wider range of locations, offering enhanced capabilities to a larger number of users.
The combination of Accu-Check SmartGuide and mySugr represents a significant improvement in diabetes management for patients. By providing a more comprehensive solution, these tools are expected to improve diabetes management for patients, ultimately contributing to better diabetes care in Europe, Latin America, and the Asia-Pacific region.
Read also:
- Is it advisable to utilize your personal health insurance in a publicly-funded medical facility?
- Dietary strategies for IBS elimination: Aims and execution methods
- Benefits, suitable dosage, and safety considerations for utilizing pumpkin seed oil in treating an overactive bladder
- Harmful Medical Remedies: A Misguided Approach to Healing
